TW202106293A - 黃病毒（ｆｌａｖｉｖｉｒｕｓ）感染症治療劑 - Google Patents

黃病毒（ｆｌａｖｉｖｉｒｕｓ）感染症治療劑 Download PDF

Info

Publication number
TW202106293A
TW202106293A TW109113893A TW109113893A TW202106293A TW 202106293 A TW202106293 A TW 202106293A TW 109113893 A TW109113893 A TW 109113893A TW 109113893 A TW109113893 A TW 109113893A TW 202106293 A TW202106293 A TW 202106293A
Authority
TW
Taiwan
Prior art keywords
ala
virus
infection
flavivirus
treatment
Prior art date
Application number
TW109113893A
Other languages
English (en)
Chinese (zh)
Inventor
増田道明
石川知弘
河田聡史
富岡基康
和田康史
Original Assignee
日商日本紐翱醫藥股份有限公司
學校法人獨協學園獨協醫科大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日本紐翱醫藥股份有限公司, 學校法人獨協學園獨協醫科大學 filed Critical 日商日本紐翱醫藥股份有限公司
Publication of TW202106293A publication Critical patent/TW202106293A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW109113893A 2019-04-26 2020-04-24 黃病毒（ｆｌａｖｉｖｉｒｕｓ）感染症治療劑 TW202106293A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-086554 2019-04-26
JP2019086554 2019-04-26

Publications (1)

Publication Number Publication Date
TW202106293A true TW202106293A (zh) 2021-02-16

Family

ID=72942078

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109113893A TW202106293A (zh) 2019-04-26 2020-04-24 黃病毒（ｆｌａｖｉｖｉｒｕｓ）感染症治療劑

Country Status (6)

Country Link
US (1) US20220193124A1 (https=)
EP (1) EP3960241A4 (https=)
JP (1) JPWO2020218577A1 (https=)
CN (1) CN113747946B (https=)
TW (1) TW202106293A (https=)
WO (1) WO2020218577A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7497790B2 (ja) * 2019-12-27 2024-06-11 国立大学法人北海道大学 豚コレラの治療及び／又は予防剤
JPWO2021215517A1 (https=) * 2020-04-22 2021-10-28

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
JP4417865B2 (ja) 2004-03-30 2010-02-17 コスモ石油株式会社 ５−アミノレブリン酸リン酸塩、その製造方法及びその用途
JP4520219B2 (ja) 2004-05-28 2010-08-04 協和発酵バイオ株式会社 ５−アミノレブリン酸の製造法
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
WO2011003071A1 (en) * 2009-07-02 2011-01-06 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods of modulating hepatitis c virus infection
WO2014013664A1 (ja) 2012-07-19 2014-01-23 Ｓｂｉファーマ株式会社 インフルエンザウイルス感染症の予防・治療剤
HK1246682A1 (en) 2015-04-10 2018-09-14 Sbi Pharmaceuticals Co., Ltd. Prophylactic/therapeutic agent for virus infections which comprises ala compound
WO2019059027A1 (ja) * 2017-09-19 2019-03-28 ネオファーマジャパン株式会社 ５－アミノレブリン酸を含むエビ目用組成物

Also Published As

Publication number Publication date
EP3960241A4 (en) 2023-06-07
US20220193124A1 (en) 2022-06-23
JPWO2020218577A1 (https=) 2020-10-29
EP3960241A1 (en) 2022-03-02
WO2020218577A1 (ja) 2020-10-29
CN113747946B (zh) 2023-08-29
CN113747946A (zh) 2021-12-03

Similar Documents

Publication Publication Date Title
CN102151256B (zh) 原儿茶酸在制备防治畜禽病毒感染性疾病的药物中的应用
AU2021205039B2 (en) Method of viral inhibition
CN113747946B (zh) 黄病毒感染症治疗剂
CN106580980B (zh) 芳香酯类化合物在制备抗肠道病毒71型药物中的应用
WO2016163082A1 (ja) Ａｌａ類を含むウイルス感染症予防／治療剤
Qiu et al. Schisandrin A: a sustainable antiviral and immunomodulatory agent against spring viraemia of carp virus in aquaculture
CN106668013A (zh) 吡啶芳香酯类化合物在制备抗肠道病毒71型药物中的应用
WO2017223178A1 (en) Treating viral infections with impdh inhibitors
Stefanou et al. Pomegranate as an anti-viral agent and immune system stimulant
WO2013147585A1 (en) A composition having antiviral activity against flavivirus
WO2021244481A1 (en) Compositions and methods for treating a sars-cov-2 infection
Deng et al. Baicalein inhibits Micropterus salmoides rhabdovirus replication in vitro and in vivo
RU2697886C1 (ru) Противовирусная композиция
WO2015135926A1 (en) Dichloroacetate compounds for use in treating a disease caused by a glycolytic parasite
WO2007106675A2 (en) Composition and method of retarding viral activity and reducing viral replication
WO2022177029A1 (ja) セレノネインを含む、ｃｏｖｉｄ１９治療又は予防薬
RU2337703C1 (ru) Средство профилактики и лечения вирусных заболеваний и способ профилактики и лечения вирусных заболеваний
TWI494104B (zh) 以抗氧化劑治療魚體內自由基引發之疾病的用途
CN118717804B (zh) 锌在防治传染性脾肾坏死病毒感染中的应用
US7282599B2 (en) Dithiocarbamate antiviral agents and methods of using same
WO2020099696A1 (es) Uso de ésteres derivados del ácido gálico como antivirales
KR20100005063A (ko) 바이러스 감염을 치료하기 위한 스타틴 및 카페인을 포함하는 조성물
CN117919378A (zh) 一种版纳绳蚋宿主防御肽Siba3的应用
CN117503776A (zh) 一种药物组合物及其用途
WO2021228714A1 (en) Antiviral composition comprising eeyarestatin i